Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Initial Results News

Page 3 - Initial Results News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Initial Results. Real-time updates on events, politics, business and more.

AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting Evaluating Epcoritamab (DuoBody®-CD3xCD20) Across B-Cell Lymphomas

December 11, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced data from multiple clinical trials evaluating epcoritamab (DuoBody®-CD3xCD20), an investigational...
United States Mohamed Zaki Genmab Duobody Data From The Observational National Lymphocare Study American Society Of Hematology Lymphoma Research Foundation
Source: prnewswire.com

Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the

November 3, 2022
Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody®-CD3xCD20) in a variety of treatment settings and hematologic malignanciesFour oral presentations highlighting data evaluating epcoritamab for the treatment of relapsed/refractory (R/R) la...
Al Qahirah United States New Orleans New Jersey David Freundel Epcoritamab Duobody
Source: pharmiweb.com

Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)

November 3, 2022
03.11.2022 - Media Release Copenhagen, Denmark, November 3, 2022 Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody-CD3xCD20) in a variety of treatment settings and hematologic ...
Al Qahirah United States New Jersey David Freundel Kalvebod Brygge Epcoritamab Monotherapy
Source: wallstreet-online.de

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)

November 3, 2022
Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody-CD3xCD20) in a variety of treatment settings and hematologic malignancies
Al Qahirah United States New Orleans New Jersey David Freundel Epcoritamab Monotherapy
Source: finanznachrichten.de

(PNT) – POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial - Press Release

September 5, 2022
INDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. PNT (the "Company" or "POINT"), a company accelerating the discovery, dev
United States France General United Kingdom Aaronr Hansen University Of Toronto Biopharma Global Inc
Source: wiredprnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science